Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2013 1
2014 1
2015 1
2016 3
2020 1
2021 2
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Exploring hTERT promoter methylation in cutaneous T-cell lymphomas.
Chebly A, Ropio J, Peloponese JM, Poglio S, Prochazkova-Carlotti M, Cherrier F, Ferrer J, Idrissi Y, Segal-Bendirdjian E, Chouery E, Farra C, Pham-Ledard A, Beylot-Barry M, Merlio JP, Tomb R, Chevret E. Chebly A, et al. Among authors: idrissi y. Mol Oncol. 2022 May;16(9):1931-1946. doi: 10.1002/1878-0261.12946. Epub 2021 Oct 12. Mol Oncol. 2022. PMID: 33715271 Free PMC article.
Spotlight on hTERT Complex Regulation in Cutaneous T-Cell Lymphomas.
Ropio J, Prochazkova-Carlotti M, Batista R, Pestana A, Chebly A, Ferrer J, Idrissi Y, Cappellen D, Durães C, Boaventura P, Vinagre J, Azzi-Martin L, Poglio S, Cabeçadas J, Campos MA, Beylot-Barry M, Sobrinho-Simões M, Merlio JP, Soares P, Chevret E. Ropio J, et al. Among authors: idrissi y. Genes (Basel). 2023 Feb 8;14(2):439. doi: 10.3390/genes14020439. Genes (Basel). 2023. PMID: 36833366 Free PMC article.
Cutaneous Lymphocyte Antigen Is a Potential Therapeutic Target in Cutaneous T-Cell Lymphoma.
Peru S, Prochazkova-Carlotti M, Cherrier F, Velazquez J, Richard E, Idrissi Y, Cappellen D, Azzi-Martin L, Pham-Ledard A, Beylot-Barry M, Merlio JP, Poglio S. Peru S, et al. Among authors: idrissi y. J Invest Dermatol. 2022 Dec;142(12):3243-3252.e10. doi: 10.1016/j.jid.2022.06.016. Epub 2022 Jul 16. J Invest Dermatol. 2022. PMID: 35850209 Free article.
Reliable blood cancer cells' telomere length evaluation by qPCR.
Ropio J, Chebly A, Ferrer J, Prochazkova-Carlotti M, Idrissi Y, Azzi-Martin L, Cappellen D, Pham-Ledard A, Soares P, Merlio JP, Chevret E. Ropio J, et al. Among authors: idrissi y. Cancer Med. 2020 May;9(9):3153-3162. doi: 10.1002/cam4.2816. Epub 2020 Mar 6. Cancer Med. 2020. PMID: 32142223 Free PMC article.
Patient-Derived Xenograft and Cell Line Models of Human Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg Type.
Prochazkova-Carlotti M, Gros A, Richard E, Cherrier F, Laharanne E, Idrissi Y, Baron C, Poglio S, Ducharme O, Menguy S, Pham-Ledard A, Beylot-Barry M, Merlio JP, Bresson-Bepoldin L. Prochazkova-Carlotti M, et al. Among authors: idrissi y. J Invest Dermatol. 2023 Feb;143(2):340-344.e6. doi: 10.1016/j.jid.2022.08.043. Epub 2022 Sep 7. J Invest Dermatol. 2023. PMID: 36084691 Free article. No abstract available.
Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells.
Chebly A, Prochazkova-Carlotti M, Idrissi Y, Bresson-Bepoldin L, Poglio S, Farra C, Beylot-Barry M, Merlio JP, Tomb R, Chevret E. Chebly A, et al. Among authors: idrissi y. Front Oncol. 2021 Oct 26;11:775253. doi: 10.3389/fonc.2021.775253. eCollection 2021. Front Oncol. 2021. PMID: 34765562 Free PMC article.
New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex.
Guillon J, Le Borgne M, Milano V, Guédin-Beaurepaire A, Moreau S, Pinaud N, Ronga L, Savrimoutou S, Albenque-Rubio S, Marchivie M, Kalout H, Walker C, Chevallier L, Buré C, Largy E, Gabelica V, Mergny JL, Baylot V, Ferrer J, Idrissi Y, Chevret E, Cappellen D, Desplat V, Schelz Z, Zupkó I. Guillon J, et al. Among authors: idrissi y. Pharmaceuticals (Basel). 2023 Dec 25;17(1):30. doi: 10.3390/ph17010030. Pharmaceuticals (Basel). 2023. PMID: 38256866 Free PMC article.
Telomerase functions beyond telomere maintenance in primary cutaneous T-cell lymphoma.
Chevret E, Andrique L, Prochazkova-Carlotti M, Ferrer J, Cappellen D, Laharanne E, Idrissi Y, Boettiger A, Sahraoui W, Ruiz F, Pham-Ledard A, Vergier B, Belloc F, Dubus P, Beylot-Barry M, Merlio JP. Chevret E, et al. Among authors: idrissi y. Blood. 2014 Mar 20;123(12):1850-9. doi: 10.1182/blood-2013-05-500686. Epub 2014 Jan 27. Blood. 2014. PMID: 24470590 Free article.
CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma.
Laharanne E, Chevret E, Idrissi Y, Gentil C, Longy M, Ferrer J, Dubus P, Jouary T, Vergier B, Beylot-Barry M, Merlio JP. Laharanne E, et al. Among authors: idrissi y. Mod Pathol. 2010 Apr;23(4):547-58. doi: 10.1038/modpathol.2009.196. Epub 2010 Jan 29. Mod Pathol. 2010. PMID: 20118908 Free article.
16 results